Huntsman Cancer Institute at the University of Utah
Dr. Heloisa Soares is a medical oncologist with a focus in GI and neuroendocrine cancers. She is an associate professor at the Huntsman Cancer Institute (HCI) at University of Utah. She serves as the Medical Director for the Clinical Trials Office as well as the co-physician leader in the GI Clinical Trials Research Group at HCI. In 2019, she was elected as a member of the board of directors for The North American Neuroendocrine Tumor Society (NANETS). Additionally, she is a member of the NCI NET taskforce and member of SWOG and NRG cooperative groups. She is also a panel member for the Neuroendocrine and Adrenal Tumors NCCN Clinical Practice Guidelines in Oncology. She is the co-chair of the A022001/ComPareNET study looking into PRRT vs CAPTEM for patients with metastatic well-differentiated pancreatic NETS and the study schair of the S2104 study looking into the role of adjuvant CAPTEM for patients with resected pancreatic NETS.
Session 10: Debate: Pancreatic NETs: PRRT vs Chemotherapy - Chemotherapy
Friday, March 31, 2023
11:45 AM – 12:00 PM ET
Session 10: Debate: Pancreatic NETs: PRRT vs Chemotherapy - Discussion
Friday, March 31, 2023
12:00 PM – 12:15 PM ET
Session 12: Debate: Pancreatic NETs: PRRT vs Chemotherapy - Chemotherapy
Thursday, August 3, 2023
3:00 PM – 3:15 PM ET
Session 12: Debate: Pancreatic NETs: PRRT vs Chemotherapy - Discussion
Thursday, August 3, 2023
3:15 PM – 3:30 PM ET